


CenTrak Cares is a charitable program dedicated to improving the quality of patient care as well as the patient experience in the communities serve. CenTrak initial project, Locating a Cure for Cancer, will focus on one individual Cancer Care organization each year.
Measure Quality. Motivate Clinicians. Maximize Incentives. Trusted Population Health. Forward Health Group’s population health measurement platforms and data strategies drive success in the move to value. Forward Health Group is awarded U.S. Patent No. 9,679,105 from the United States Patent and Trademark Office (USPTO). The patent name is System and method for the visualization of medical data. The patent is the first of its kind in the population health data analytics industry and covers data processes and visualizations that solve the ongoing challenge facing healthcare—data interoperability and validity.
One of the very early providers of EPCS, PrognoCIS enables users to seamlessly and securely transmit e-prescriptions to pharmacies for DEA class I, II, III, IV, and V. The feature enforces two-factor authentication for prescription of narcotic drugs to ensure that drugs are not prescribed by unauthorized employees like medical assistants, nurses or administrative staff. PrognoCIS, as well as Surescripts®, keeps track of every prescription for auditing purposes. It then makes those prescriptions available as part of a patient’s medication history, regardless of where and by whom the prescription was given.











